Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies

References

• Kovanen PE, Leonard WJ. Cytokines and immunodeficiency diseases: critical roles of the γc-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev.202, 67–83 (2004).
   PubMed Web of Science ®Google Scholar
• Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int. Rev. Immunol.16(3–4), 345–364 (1998).
   PubMedGoogle Scholar
• Radwanska M, Cutler AJ, Hoving JC et al. Deletion of IL-4Rα on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. PLoS Pathog.3(5), E68 (2007).
   Google Scholar
• Trigueros C, Hozumi K, Silva-Santos B et al. Pre-TCR signaling regulates IL-7 receptor α expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur. J. Immunol.33(7), 1968–1977 (2003).
   PubMed Web of Science ®Google Scholar
• Cao X, Shores EW, Hu-Li J et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity2(3), 223–238 (1995).
   PubMed Web of Science ®Google Scholar
• Combe CL, Moretto MM, Schwartzman JD et al. Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite. Proc. Natl Acad. Sci. USA103(17), 6635–6640 (2006).
   PubMed Web of Science ®Google Scholar
• Cui FD, Asada H, Jin ML et al. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther.12(2), 160–168 (2005).
   PubMed Web of Science ®Google Scholar
• Bolesta E, Kowalczyk A, Wierzbicki A et al. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J. Immunol.177(1), 177–191 (2006).
   PubMed Web of Science ®Google Scholar
• Teague RM, Sather BD, Sacks JA et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nat. Med.12(3), 335–341 (2006).
   PubMed Web of Science ®Google Scholar
• Dooms H, Abbas AK. Control of CD4+ T-cell memory by cytokines and costimulators. Immunol. Rev.211, 23–38 (2006).
   PubMed Web of Science ®Google Scholar
• Yajima T, Nishimura H, Sad S et al. A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection. J. Immunol.174(6), 3590–3597 (2005).
   PubMed Web of Science ®Google Scholar
• Kasaian MT, Whitters MJ, Carter LL et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity16(4), 559–569 (2002).
   PubMed Web of Science ®Google Scholar
• Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med.195(12), 1541–1548 (2002).
   PubMed Web of Science ®Google Scholar
• Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol. Rev.211, 154–163 (2006).
   PubMed Web of Science ®Google Scholar
• Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol.26(3), 172–176 (2005).
   PubMed Web of Science ®Google Scholar
• Osborne LC, Dhanji S, Snow JW et al. Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R α mutant mice. J. Exp. Med.204(3), 619–631 (2007).
   PubMed Web of Science ®Google Scholar
• Casey KA, Mescher MF. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. J. Immunol.178(12), 7640–7648 (2007).
   PubMed Web of Science ®Google Scholar
• Alves NL, Arosa FA, van Lier RA. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J. Immunol.175(2), 755–762 (2005).
   PubMed Web of Science ®Google Scholar
• Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol.89(Pt 1), 1–47 (2008).
   PubMed Web of Science ®Google Scholar
• Walzer T, Dalod M, Vivier E, Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin. Biol. Ther.5(Suppl. 1), S49–S59 (2005).
   PubMed Web of Science ®Google Scholar
• Howe RC, Dhiman N, Ovsyannikova IG, Poland GA. Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus. Clin. Exp. Immunol.140(2), 333–342 (2005).
   PubMed Web of Science ®Google Scholar
• Boritz E, Palmer BE, Wilson CC. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J. Virol.78(22), 12638–12646 (2004).
   PubMed Web of Science ®Google Scholar
• Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol.21, 29–70 (2003).
   PubMed Web of Science ®Google Scholar
• Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and T-cell homeostasis. Curr. Opin. Immunol.19(3), 320–326 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson CB, Marcuse EK. Vaccine safety – vaccine benefits: science and the public’s perception. Nat. Rev. Immunol.1(2), 160–165 (2001).
   PubMed Web of Science ®Google Scholar
• Mossman KL, Ashkar AA. Herpesviruses and the innate immune response. Viral Immunol.18(2), 267–281 (2005).
   PubMed Web of Science ®Google Scholar
• Brideau-Andersen AD, Huang X, Sun SC et al. Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases. Proc. Natl Acad. Sci. USA104(20), 8269–8274 (2007).
   PubMed Web of Science ®Google Scholar
• Gosselin J, TomoIu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood94(12), 4210–4219 (1999).
   PubMed Web of Science ®Google Scholar
• Gill N, Ashkar AA. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur. J. Immunol.37(9), 2529–2538 (2007).
   PubMed Web of Science ®Google Scholar
• Purton JF, Tan JT, Rubinstein MP et al. Antiviral CD4+ memory T cells are IL-15 dependent. J. Exp. Med.204(4), 951–961 (2007).
   PubMed Web of Science ®Google Scholar
• Alves NL, Hooibrink B, Arosa FA, van Lier RA. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood102(7), 2541–2546 (2003).
   PubMed Web of Science ®Google Scholar
• Kokaji AI, Hockley DL, Kane KP. IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells. J. Immunol.180(7), 4391–4401 (2008).
   PubMed Web of Science ®Google Scholar
• Brady J, Hayakawa Y, Smyth MJ, Nutt SL. IL-21 induces the functional maturation of murine NK cells. J. Immunol.172(4), 2048–2058 (2004).
   PubMed Web of Science ®Google Scholar
• Wang G, Tschoi M, Spolski R et al.In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res.63(24), 9016–9022 (2003).
   PubMed Web of Science ®Google Scholar
• Brandt K, Bulfone-Paus S, Foster DC, Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood102(12), 4090–4098 (2003).
   PubMed Web of Science ®Google Scholar
• Caprioli F, Sarra M, Caruso R et al. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol.180(3), 1800–1807 (2008).
   PubMed Web of Science ®Google Scholar
• Kuchen S, Robbins R, Sims GP et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell–B cell collaboration. J. Immunol.179(9), 5886–5896 (2007).
   PubMed Web of Science ®Google Scholar
• Allard EL, Hardy MP, Leignadier J et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur. J. Immunol.37(11), 3069–3077 (2007).
   PubMed Web of Science ®Google Scholar
• Ostiguy V, Allard EL, Marquis M, Leignadier J, Labrecque N. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J. Leukoc. Biol.82(3), 645–656 (2007).
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Gamadia LE, Baars PA et al. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+T cells. J. Immunol.169(10), 5838–5843 (2002).
   PubMed Web of Science ®Google Scholar
• Ozaki K, Spolski R, Feng CG et al. A critical role for IL-21 in regulating immunoglobulin production. Science298(5598), 1630–1634 (2002).
   PubMed Web of Science ®Google Scholar
• Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol.6(8), 595–601 (2006).
   PubMed Web of Science ®Google Scholar
• Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol.24, 657–679 (2006).
   PubMed Web of Science ®Google Scholar
• Ohteki T, Tada H, Ishida K et al. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med.203(10), 2329–2338 (2006).
   PubMed Web of Science ®Google Scholar
• Burkett PR, Koka R, Chien M et al. Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med.200(7), 825–834 (2004).
   PubMed Web of Science ®Google Scholar
• Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science264(5161), 965–968 (1994).
   PubMed Web of Science ®Google Scholar
• Nishimura H, Yajima T, Naiki Y et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med.191(1), 157–170 (2000).
   PubMed Web of Science ®Google Scholar
• Tan X, Lefrancois L. Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium. Genes Immun.7(5), 407–416 (2006).
   PubMed Web of Science ®Google Scholar
• Nishimura H, Fujimoto A, Tamura N et al. A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing. FASEB J.19(1), 19–28 (2005).
   PubMed Web of Science ®Google Scholar
• Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity17(5), 537–547 (2002).
   PubMed Web of Science ®Google Scholar
• Sato N, Patel HJ, Waldmann TA, Tagaya Y. The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl Acad. Sci. USA104(2), 588–593 (2007).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Dubois S, Sato N et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood105(2), 721–727 (2005).
   PubMed Web of Science ®Google Scholar
• Bulanova E, Budagian V, Duitman E et al. Soluble interleukin IL-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J. Biol. Chem.282(18), 13167–13179 (2007).
   PubMed Web of Science ®Google Scholar
• Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity21(5), 733–741 (2004).
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Takesue M, Kobayashi N et al. Evaluation of Toll-like receptor 4 gene expression of immortalized human liver cell lines. Transplant. Proc.35(1), 431–432 (2003).
   PubMed Web of Science ®Google Scholar
• Coccia EM, Severa M, Giacomini E et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol.34(3), 796–805 (2004).
   PubMed Web of Science ®Google Scholar
• Hon H, Jacob J. Tracking dendritic cells in vivo: insights into DC biology and function. Immunol. Res.29(1–3), 69–80 (2004).
   PubMed Web of Science ®Google Scholar
• Kuwajima S, Sato T, Ishida K et al. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol.7(7), 740–746 (2006).
   PubMed Web of Science ®Google Scholar
• Pulendran B. Division of labor and cooperation between dendritic cells. Nat. Immunol.7(7), 699–700 (2006).
   PubMed Web of Science ®Google Scholar
• Hultcrantz M, Huhn MH, Wolf M et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology367(1), 92–101 (2007).
   PubMed Web of Science ®Google Scholar
• Andoniou CE, van Dommelen SL, Voigt V et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol.6(10), 1011–1019 (2005).
   PubMed Web of Science ®Google Scholar
• Huntington ND, Puthalakath H, Gunn P et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol.8(8), 856–863 (2007).
   PubMed Web of Science ®Google Scholar
• Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol.77(18), 10168–10171 (2003).
   PubMed Web of Science ®Google Scholar
• Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity26(4), 503–517 (2007).
   PubMed Web of Science ®Google Scholar
• Liu G, Zhai Q, Schaffner D et al. IL-15 induces IFN-β and iNOS gene expression, and antiviral activity of murine macrophage RAW 264.7 cells. Immunol. Lett.91(2–3), 171–178 (2004).
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Isakov D, Zhu Q et al. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host. J. Immunol.177(9), 6336–6343 (2006).
   PubMed Web of Science ®Google Scholar
• Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat. Med.14(6), 623–628 (2008).
   PubMed Web of Science ®Google Scholar
• Masopust D, Vezys V, Wherry EJ, Ahmed R. A brief history of CD8 T cells. Eur. J. Immunol.37(Suppl. 1), S103–S110 (2007).
   PubMed Web of Science ®Google Scholar
• Stemberger C, Neuenhahn M, Buchholz VR, Busch DH. Origin of CD8+ effector and memory T cell subsets. Cell. Mol. Immunol.4(6), 399–405 (2007).
   PubMed Web of Science ®Google Scholar
• Sandau MM, Winstead CJ, Jameson SC. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J. Immunol.179(1), 120–125 (2007).
   PubMed Web of Science ®Google Scholar
• Yajima T, Yoshihara K, Nakazato K et al. IL-15 regulates CD8+T cell contraction during primary infection. J. Immunol.176(1), 507–515 (2006).
   PubMed Web of Science ®Google Scholar
• Wallace DL, Berard M, Soares MV et al. Prolonged exposure of naive CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology119(2), 243–253 (2006).
   PubMed Web of Science ®Google Scholar
• Sauce D, Larsen M, Curnow SJ et al. EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood108(1), 11–18 (2006).
   PubMed Web of Science ®Google Scholar
• Virgin HW. Immune regulation of viral infection and vice versa. Immunol. Res.32(1–3), 293–315 (2005).
   PubMed Web of Science ®Google Scholar
• Oldstone MB. Viral persistence: parameters, mechanisms and future predictions. Virology344(1), 111–118 (2006).
   PubMed Web of Science ®Google Scholar
• Kohlmeier JE, Miller SC, Woodland DL. Cutting edge: antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J. Immunol.178(8), 4721–4725 (2007).
   PubMed Web of Science ®Google Scholar
• Khanna KM, Lepisto AJ, Decman V, Hendricks RL. Immune control of herpes simplex virus during latency. Curr. Opin. Immunol.16(4), 463–469 (2004).
   PubMed Web of Science ®Google Scholar
• Sheridan BS, Khanna KM, Frank GM, Hendricks RL. Latent virus influences the generation and maintenance of CD8+ T cell memory. J. Immunol.177(12), 8356–8364 (2006).
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Ha SJ, Kaech SM et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity27(4), 670–684 (2007).
   PubMed Web of Science ®Google Scholar
• Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol.19(4), 408–415 (2007).
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl Acad. Sci. USA101(45), 16004–16009 (2004).
   PubMed Web of Science ®Google Scholar
• Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature408(6808), 57–63 (2000).
   PubMed Web of Science ®Google Scholar
• Coquet JM, Kyparissoudis K, Pellicci DG et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol.178(5), 2827–2834 (2007).
   PubMed Web of Science ®Google Scholar
• Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl Acad. Sci. USA97(21), 11439–11444 (2000).
   PubMed Web of Science ®Google Scholar
• Distler JH, Jungel A, Kowal-Bielecka O et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum.52(3), 856–864 (2005).
   PubMed Web of Science ®Google Scholar
• Jin H, Carrio R, Yu A, Malek TR. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol.173(1), 657–665 (2004).
   PubMed Web of Science ®Google Scholar
• Sivori S, Cantoni C, Parolini S et al. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol.33(12), 3439–3447 (2003).
   PubMed Web of Science ®Google Scholar
• Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol.169(7), 3600–3605 (2002).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol.19(6), 652–657 (2007).
   PubMed Web of Science ®Google Scholar
• Reiner SL. Development in motion: helper T cells at work. Cell129(1), 33–36 (2007).
   PubMed Web of Science ®Google Scholar
• Wurster AL, Rodgers VL, Satoskar AR et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med.196(7), 969–977 (2002).
   PubMed Web of Science ®Google Scholar
• Suto A, Wurster AL, Reiner SL, Grusby MJ. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol.177(6), 3721–3727 (2006).
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature448(7152), 480–483 (2007).
   PubMed Web of Science ®Google Scholar
• Zeng R, Spolski R, Casas E et al. The molecular basis of IL-21-mediated proliferation. Blood109(10), 4135–4142 (2007).
   PubMed Web of Science ®Google Scholar
• White L, Krishnan S, Strbo N et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood109(9), 3873–3880 (2007).
   PubMed Web of Science ®Google Scholar
• Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol.26, 57–79 (2008).
   PubMed Web of Science ®Google Scholar
• Dou J, Tang Q, Zhao F et al. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and bacillus Calmette–Guerin. Immunol. Invest.37(2), 113–127 (2008).
   PubMed Web of Science ®Google Scholar
• Curtsinger JM, Johnson CM, Mescher MF. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol.171(10), 5165–5171 (2003).
   PubMed Web of Science ®Google Scholar
• Hernandez J, Aung S, Marquardt K, Sherman LA. Uncoupling of proliferative potential and gain of effector function by CD8+ T cells responding to self-antigens. J. Exp. Med.196(3), 323–333 (2002).
   PubMed Web of Science ®Google Scholar
• Sille FC, Visser A, Boes M. T cell priming by tissue-derived dendritic cells: new insights from recent murine studies. Cell. Immunol.237(2), 77–85 (2005).
   PubMed Web of Science ®Google Scholar
• Zeng R, Spolski R, Finkelstein SE et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med.201(1), 139–148 (2005).
   PubMed Web of Science ®Google Scholar
• Gagnon J, Ramanathan S, Leblanc C, Ilangumaran S. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8+ T lymphocytes. Cell. Signal.19(4), 806–816 (2007).
   PubMed Web of Science ®Google Scholar
• Luciano AA, Lederman MM, Valentin-Torres A, Bazdar DA, Sieg SF. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. J. Immunol.179(6), 3543–3549 (2007).
   PubMed Web of Science ®Google Scholar
• Hendriks J, Gravestein LA, Tesselaar K et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol.1(5), 433–440 (2000).
   PubMed Web of Science ®Google Scholar
• Gamadia LE, van Leeuwen EM, Remmerswaal EB et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol.172(10), 6107–6114 (2004).
   PubMed Web of Science ®Google Scholar
• Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J. Gen. Virol.87(Pt 7), 1763–1779 (2006).
   PubMed Web of Science ®Google Scholar
• Weninger W, Manjunath N, von Andrian UH. Migration and differentiation of CD8+ T cells. Immunol. Rev.186, 221–233 (2002).
   PubMed Web of Science ®Google Scholar
• Holm C, Nyvold CG, Paludan SR, Thomsen AR, Hokland M. Interleukin-21 mRNA expression during virus infections. Cytokine33(1), 41–45 (2006).
   PubMed Web of Science ®Google Scholar
• Strengell M, Matikainen S, Siren J et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol.170(11), 5464–5469 (2003).
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines7(2), 175–191 (2008).
   PubMed Web of Science ®Google Scholar
• Dhama K, Mahendran M, Gupta PK, Rai A. DNA vaccines and their applications in veterinary practice: current perspectives. Vet. Res. Commun.32(5), 341–356 (2008).
   PubMed Web of Science ®Google Scholar
• Hiromatsu T, Yajima T, Matsuguchi T et al. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-α-induced apoptosis. J. Infect. Dis.187(9), 1442–1451 (2003).
   PubMed Web of Science ®Google Scholar
• Rausch A, Hessmann M, Holscher A et al. Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+T cells. Eur. J. Immunol.36(5), 1156–1167 (2006).
   PubMed Web of Science ®Google Scholar
• d’Ettorre G, Andreotti M, Carnevalini M et al. Interleukin-15 enhances the secretion of IFN-γ and CC chemokines by natural killer cells from HIV viremic and aviremic patients. Immunol. Lett.103(2), 192–195 (2006).
   PubMed Web of Science ®Google Scholar
• Li W, Li S, Hu Y et al. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting. Vaccine26(26), 3282–3290 (2008).
   PubMed Web of Science ®Google Scholar
• Boyer JD, Robinson TM, Kutzler MA et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc. Natl Acad. Sci. USA104(47), 18648–18653 (2007).
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Robinson TM, Chattergoon MA et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J. Immunol.175(1), 112–123 (2005).
   PubMed Web of Science ®Google Scholar
• Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J. Immunol.177(9), 6072–6080 (2006).
   PubMed Web of Science ®Google Scholar
• Marzec M, Liu X, Kasprzycka M et al. IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. Blood111(4), 2181–2189 (2008).
   PubMed Web of Science ®Google Scholar
• Davis ID, Skak K, Smyth MJ et al. Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res.13(23), 6926–6932 (2007).
   PubMed Web of Science ®Google Scholar
• de Totero D, Meazza R, Zupo S et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood107(9), 3708–3715 (2006).
   PubMed Web of Science ®Google Scholar
• Moroz A, Eppolito C, Li Q et al. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J. Immunol.173(2), 900–909 (2004).
   PubMed Web of Science ®Google Scholar
• Prlic M, Hernandez-Hoyos G, Bevan MJ. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J. Exp. Med.203(9), 2135–2143 (2006).
   PubMed Web of Science ®Google Scholar
• Blachere NE, Morris HK, Braun D et al. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J. Immunol.176(12), 7288–7300 (2006).
   PubMed Web of Science ®Google Scholar
• Wan N, Dai H, Wang T et al. Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection. J. Immunol.180(1), 113–121 (2008).
   PubMed Web of Science ®Google Scholar
• Vezys V, Masopust D, Kemball CC et al. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med.203(10), 2263–2269 (2006).
   PubMed Web of Science ®Google Scholar
• Shin H, Blackburn SD, Blattman JN, Wherry EJ. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med.204(4), 941–949 (2007).
   PubMed Web of Science ®Google Scholar